|
URB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.535700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.000000E-01 |
| Normal-vs-Stage2 |
1.601000E-01 |
| Normal-vs-Stage3 |
1.926290E-02 |
| Normal-vs-Stage4 |
6.808000E-02 |
| Stage1-vs-Stage2 |
4.332400E-01 |
| Stage1-vs-Stage3 |
1.230200E-01 |
| Stage1-vs-Stage4 |
2.611200E-01 |
| Stage2-vs-Stage3 |
8.275400E-01 |
| Stage2-vs-Stage4 |
8.683000E-01 |
| Stage3-vs-Stage4 |
9.847400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.720000E-02 |
| Normal-vs-AfricanAmerican |
5.517000E-01 |
| Normal-vs-Asian |
2.532200E-01 |
| Caucasian-vs-AfricanAmerican |
5.913000E-01 |
| Caucasian-vs-Asian |
8.284800E-01 |
| AfricanAmerican-vs-Asian |
6.612000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.776300E-03 |
| Normal-vs-Female |
8.762000E-01 |
| Male-vs-Female |
8.202700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.243400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.503600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.793050E-01 |
| Normal-vs-Age(81-100Yrs) |
4.297000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.649800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.173600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.263000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.415000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.070800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.978200E-01 |
| Normal-vs-Grade 2 |
3.564600E-01 |
| Normal-vs-Grade 3 |
1.299600E-02 |
| Normal-vs-Grade 4 |
3.162300E-02 |
| Grade 1-vs-Grade 2 |
4.113400E-01 |
| Grade 1-vs-Grade 3 |
2.898000E-01 |
| Grade 1-vs-Grade 4 |
2.840000E-01 |
| Grade 2-vs-Grade 3 |
1.176010E-01 |
| Grade 2-vs-Grade 4 |
1.625040E-01 |
| Grade 3-vs-Grade 4 |
9.206400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.130600E-01 |
| Normal-vs-ccB subtype |
4.343200E-03 |
| ccA subtype-vs-ccB subtype |
1.038160E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.790400E-02 |
| Normal-vs-N1 |
9.299600E-01 |
| N0-vs-N1 |
4.580000E-01 |
|
|
